Assessment of polyneuropathy

References

Key articles

Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-Second revision. J Peripher Nerv Syst. 2021 Sep;26(3):242-68.Full text  Abstract

Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017 Jan;40(1):136-154.Full text  Abstract

England JD, Gronseth GS, Franklin G, et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009 (reaffirmed Jan 2019);72:185-92. Abstract

Reference articles

1. Italian General Practitioner Study Group (IGPSG). Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology. 1995;45:1832-1836. Abstract

2. Bharucha NE, Bharucha AE, Bharucha EP. Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology. 1991;41:1315-1317. Abstract

3. Savettieri G, Rocca WA, Salemi G, Meneghini F, et al. Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology. 1993;43:1115-1120. Abstract

4. Hanewinckel R, van Oijen M, Ikram MA, et al. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016 Jan;31(1):5-20.Full text  Abstract

5. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993 Apr;43(4):817-24. Abstract

6. Simpson DM, Kitch D, Evans SR et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology. 2006;66:1679-1687. Abstract

7. Shy ME, Frohman EM, So YT, et al. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003 Mar 25;60(6):898-904.Full text  Abstract

8. Devigili G, Cazzato D, Lauria G. Clinical diagnosis and management of small fiber neuropathy: an update on best practice. Expert Rev Neurother. 2020 Sep;20(9):967-80. Abstract

9. Oaklander AL, Nolano M. Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review. JAMA Neurol. 2019 Oct 1;76(10):1240-1251. Abstract

10. Devigili G, Rinaldo S, Lombardi R, et al. Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain. 2019 Dec 1;142(12):3728-3736.Full text  Abstract

11. Gondim FAA, Barreira AA, Claudino R, et al. Definition and diagnosis of small fiber neuropathy: consensus from the Peripheral Neuropathy Scientific Department of the Brazilian Academy of Neurology. Arq Neuropsiquiatr. 2018 Mar;76(3):200-208.Full text  Abstract

12. de Greef BTA, Hoeijmakers JGJ, Gorissen-Brouwers CML, et al. Associated conditions in small fiber neuropathy - a large cohort study and review of the literature. Eur J Neurol. 2018 Feb;25(2):348-355.Full text  Abstract

13. Novella SP, Inzucchi SE, Goldstein JM: The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve. 2001;24:1229-1231. Abstract

14. Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve. 2001;24:1225-1228. Abstract

15. Tagliati M, Grinnel J, Godbold J, et al. Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol. 1999;56:84-89.Full text  Abstract

16. Childs EA, Lyles RH, Selnes OA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. 1999;52:607-613. Abstract

17. Kullberg BJ, Vrijmoeth HD, van de Schoor F, et al. Lyme borreliosis: diagnosis and management. BMJ. 2020 May 26;369:m1041. Abstract

18. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis, and treatment of lyme disease. Arthritis Rheumatol. 2021 Jan;73(1):12-20.Full text  Abstract

19. Kaminsky AL, Maisonobe T, Lenglet T, et al. Confirmed cases of Neuroborreliosis with involvement of peripheral nervous system: Description of a cohort. Medicine (Baltimore). 2020 Oct 2;99(40):e21986.Full text  Abstract

20. Logina I, Donaghy M. Diphtheritic polyneuropathy: a clinical study and comparison with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):433-8.Full text  Abstract

21. Wakerley BR, Yuki N. Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes. Pract Neurol. 2015 Apr;15(2):90-9.Full text  Abstract

22. Gwathmey KG, Pearson KT. Diagnosis and management of sensory polyneuropathy. BMJ. 2019 May 8;365:l1108. Abstract

23. Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-Second revision. J Peripher Nerv Syst. 2021 Sep;26(3):242-68.Full text  Abstract

24. Thawani SP, Brannagan TH 3rd, Lebwohl B, et al. Risk of Neuropathy Among 28,232 Patients With Biopsy-Verified Celiac Disease. JAMA Neurol. 2015 Jul;72(7):806-11.Full text  Abstract

25. Zis P, Sarrigiannis PG, Rao DG, et al. Gluten neuropathy: prevalence of neuropathic pain and the role of gluten-free diet. J Neurol. 2018 Oct;265(10):2231-2236. Abstract

26. Notermans NC, Wokke JHJ, Lokhorst HM, et al. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. Brain. 1994;117:1385-1393. Abstract

27. Kaku M, Berk JL. Neuropathy Associated with Systemic Amyloidosis. Semin Neurol. 2019 Oct;39(5):578-88. Abstract

28. Camdessanché JP, Antoine JC, Honnorat J, et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain. 2002 Jan;125(pt 1):166-75.Full text  Abstract

29. Sukumar N, Saravanan P. Investigating vitamin B12 deficiency. BMJ. 2019 May 10;365:l1865. Abstract

30. Mazokopakis EE, Starakis IK. Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency. Diabetes Res Clin Pract. 2012 Sep;97(3):359-67. Abstract

31. Jung SB, Nagaraja V, Kapur A, et al. Association between vitamin B12 deficiency and long-term use of acid-lowering agents: a systematic review and meta-analysis. Intern Med J. 2015 Apr;45(4):409-16. Abstract

32. Linnebank M, Moskau S, Semmler A, et al. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol. 2011 Feb;69(2):352-9. Abstract

33. Owczarek D, Rodacki T, Domagała-Rodacka R, et al. Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol. 2016 Jan 21;22(3):895-905.Full text  Abstract

34. Mohamed M, Thio J, Thomas RS, et al. Pernicious anaemia. BMJ. 2020 Apr 24;369:m1319. Abstract

35. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. 2018 [internet publication].Full text

36. Morales D, Pacurariu A, Slattery J, et al. Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy. JAMA Neurol. 2019 Jul 1;76(7):827-833.Full text  Abstract

37. Gertz MA, Mauermann ML, Grogan M, et al. Advances in the treatment of hereditary transthyretin amyloidosis: A review. Brain Behav. 2019 Sep;9(9):e01371.Full text  Abstract

38. Adams D, Ando Y, Beirão JM, et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol. 2021 Jun;268(6):2109-22.Full text  Abstract

39. Freeman R, Gewandter JS, Faber CG, et al. Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria. Neurology. 2020 Dec 1;95(22):1005-1014. Abstract

40. Hanewinckel R, van Oijen M, Ikram MA, et al. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016 Jan;31(1):5-20.Full text  Abstract

41. Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol. 2001 Jun;58(6):893-8.Full text  Abstract

42. Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017 Jan;40(1):136-154.Full text  Abstract

43. Kwok T, Ting PT, Wong EK, et al. Peripheral neuropathy for dermatologists: what if not diabetic neuropathy? J Cutan Med Surg. 2013 Oct;17 Suppl 1:S1-5. Abstract

44. National Institute for Health and Care Excellence. Neuropad for detecting preclinical diabetic peripheral neuropathy. Sep 2018 [internet publication].Full text

45. Dros J, Wewerinke A, Bindels PJ, et al. Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review. Ann Fam Med. 2009 Nov-Dec;7(6):555-8.Full text  Abstract

46. Rosenberg NR, Portegies P, de Visser M, et al. Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline. J Neurol Neurosurg Psychiatry. 2001;71:205-209.Full text  Abstract

47. England JD, Gronseth GS, Franklin G, et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009 (reaffirmed Jan 2019);72:185-92. Abstract

48. Hughes RA. Peripheral neuropathy. BMJ. 2002;324:466-469.Full text  Abstract

49. Lang M, Treister R, Oaklander AL. Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy. J Neurol. 2016 Dec;263(12):2515-2527.Full text  Abstract

50. Berenson JR, Anderson KC, Audell RA, et al. Monoclonal gammopathy of undetermined significance: a consensus statement. Br J Haematol. 2010 Jul;150(1):28-38.Full text  Abstract

51. England JD, Gronseth GS, Franklin G, et al; American Academy ofNeurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve. 2009;39:116-125. Abstract

52. England JD, Asbury AK. Peripheral neuropathy. Lancet. 2004 Jun 26;363(9427):2151-61.Full text  Abstract

53. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014 Jan;37(suppl 1):S81-90.Full text  Abstract

54. Shabeeb D, Najafi M, Hasanzadeh G, et al. Electrophysiological measurements of diabetic peripheral neuropathy: a systematic review. Diabetes Metab Syndr. 2018 Jul;12(4):591-600. Abstract

55. Mindel A, Tenant-Flowers M. ABC of AIDS: Natural history and management of early HIV infection. BMJ. 2001;322:1290-1293.Full text  Abstract

56. Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Oral involvement in Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome. Ann Rheum Dis. 1994;53;637-647.Full text  Abstract

57. Carsons S. A review and update of Sjogren's syndrome: manifestations, diagnosis and treatment. Am J Manag Care. 2001;7(suppl 14):S433-S443. Abstract

58. Brennan MT, Sankar V, Leakan RA, at al. Risk factors for positive minor salivary gland biopsy findings in Sjogren's syndrome and dry mouth patients. Arthritis Rheum. 2002;47:189-195. Abstract

59. Leuchten N, Hoyer A, Brinks R, et al. Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic Data. Arthritis Care Res (Hoboken). 2018 Mar;70(3):428-438.Full text  Abstract

60. Nashi RA, Shmerling RH. Antinuclear antibody testing for the diagnosis of systemic lupus erythematosus. Med Clin North Am. 2021 Mar;105(2):387-96. Abstract

61. Falk RH, Comenzo RL, Skinner M. Review article: medical progress. The systemic amyloidoses. N Eng J Med. 1997;337:898-909. Abstract

62. Oo TH. Diagnostic difficulties in pernicious anemia. Discov Med. 2019 Nov-Dec;28(155):247-53.Full text  Abstract

63. Mead P, Petersen J, Hinckley A. Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):703.Full text  Abstract

64. Kumar N, Gross JB Jr, Ahlskog JE: Myelopathy due to copper deficiency. Neurology. 2003;61:273-274. Abstract

65. Sun A. Lysosomal storage disease overview. Ann Transl Med. 2018 Dec;6(24):476.Full text  Abstract

66. Brady RO, Schiffmann R. Clinical features of and recent advances in therapy for Fabry Disease. JAMA. 2000;284:2771-2775. Abstract

67. Eng CM, Germain DP, Banikazemi M, et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med. 2006 Sep;8(9):539-48.Full text  Abstract

68. Ortiz A, Germain DP, Desnick RJ, et al. Fabry disease revisited: Management and treatment recommendations for adult patients. Mol Genet Metab. 2018 Apr;123(4):416-427.Full text  Abstract

69. Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD et al. Refusm disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation. J Neurochem. 2002;80:727-735. Abstract

70. Sinha S, Mahadevan A, Lokesh L, et al. Tangier disease-a diagnostic challenge in countries endemic for leprosy. J Neurol Neurosurg and Psychiatry. 2004;75:301-304.Full text  Abstract

71. Hermans G, De Jonghe B, Bruyninckx F, et al. Clinical review: critical illness polyneuropathy and myopathy. Crit Care. 2008;12:238. Abstract

72. American College of Radiology. ACR Appropriateness Criteria. Low back pain. 2021 [internet publication].Full text

73. Expert panels on neurological imaging, interventional radiology, and musculoskeletal imaging:., Shah LM, Jennings JW, et al. ACR appropriateness criteria<sup>®</sup> management of vertebral compression fractures. J Am Coll Radiol. 2018 Nov;15(11s):S347-S364.Full text  Abstract

Use of this content is subject to our disclaimer